Reuse Premarket Guidance Calls For Close Collaboration Between ODE and OC
This article was originally published in The Gray Sheet
Executive Summary
CDRH will rely on quality system inspections, rather than premarket submissions, to review reprocessors' quality control procedures for evaluating incoming products, according to a May 24 guidance on single-use device (SUD) reuse.
You may also be interested in...
General Controls, Inspections Suffice For Reprocessed Class I Forceps - FDA
Process validation compliance and monitoring of manufacturing provide reasonable assurances that reprocessed single-use non-electric biopsy forceps are sterile, FDA argues in denying a Boston Scientific citizen petition.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.